New findings from researchers at The University of Texas MD Anderson Cancer Center about how some cancer cells become "addicted" to glucose could open up fresh approaches to therapy strategies for cancers with high levels ...
Mar 30, 2020
0
90
Children with aggressive blood cancers have differences—not just in the DNA code of their blood cells—but also in the heavily twisted protein superstructure that controls access to genes.
Mar 23, 2020
0
134
St. Jude Children's Research Hospital scientists have discovered a gene associated with about half of glucocorticoid resistance in children with the most common pediatric cancer. Researchers have also identified a drug that ...
Mar 9, 2020
0
101
Researchers with Nemours Children's Health System utilized Next Generation Sequencing (NGS) to more precisely identify genomic characteristics of leukemias in children, the most common childhood cancer. The study, published ...
Mar 5, 2020
0
2
Scientists at St. Jude Children's Research Hospital and Princess Margaret Cancer Centre in Toronto, Canada, have reported that subpopulations of leukemic cells present at diagnosis can cause relapse in children with acute ...
Mar 3, 2020
0
9
(HealthDay)—Dengue virus infection is associated with an increased risk for leukemia, according to a study published online Feb. 12 in Cancer Epidemiology, Biomarkers & Prevention.
Feb 21, 2020
0
0
The loss of one copy of the miR15a/miR16-1 gene cluster promoted initiation and progression of multiple myeloma in mice.
Feb 20, 2020
0
0
DGIST researchers have identified the causes of hypersensitivity accompanied by neurodevelopmental disorders such as autism-spectrum disorder (ASD). This is expected to make huge contributions to the early diagnosis of sensory-defective ...
Feb 14, 2020
0
40
Acute myeloid leukemia (AML), a blood cancer affecting both adults and children, requires more than one genetic "hit" to develop. As we age, many of us acquire a mutation that enables certain of our blood cells to multiply ...
Feb 14, 2020
1
340
According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord blood-derived chimeric antigen receptor (CAR) natural killer (NK)-cell therapy targeting CD19 resulted ...
Feb 5, 2020
0
27
